CIK 0001754195 · Medicinal Chemicals & Botanical Products (SIC 2833) · NYSE · incorporated in A1 · fiscal year ends 12/31
| FY2025 | FY2024 | |
|---|---|---|
| Revenue (USD) | 1.2 B | 1.2 B |
| Diluted EPS (USD/shares) | -0.58 | -0.95 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-08-24 | S-8 POS | S-8 POS | |
| 2026-08-24 | POSASR | POSASR | |
| 2026-08-11 | 8-K | 8-K items 1.01,3.02,3.03,5.03,9.01 | 2026-08-11 |
| 2026-08-07 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-07 | 8-K | 8-K items 2.01,7.01,9.01 | 2026-08-07 |
| 2026-08-05 | 8-K | 8-K items 5.07,9.01 | 2026-08-05 |
| 2026-07-08 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-07-02 | 8-K | 8-K items 5.02,9.01 | 2026-06-30 |
| 2026-06-26 | 4 | 4 | 2026-06-26 |
| 2026-06-25 | 4 | 4 | 2026-06-23 |
| 2026-06-25 | DEF 14A | DEF 14A | 2026-06-25 |
| 2026-06-25 | DEFA14A | DEFA14A | |
| 2026-06-22 | 4 | 4 | 2026-06-17 |
| 2026-06-17 | 144 | 144 | |
| 2026-06-12 | PRE 14A | PRE 14A | 2026-06-08 |
| 2026-06-12 | 8-K | 8-K items 5.02,9.01 | 2026-06-11 |
| 2026-06-11 | 8-K | 8-K items 5.07,9.01 | 2026-06-09 |
| 2026-06-09 | CERT | NYSE CERTIFICATION | |
| 2026-06-09 | 8-K | 8-K items 8.01,9.01 | 2026-06-09 |
| 2026-06-09 | 8-A12B | 8-A12B | |
| 2026-06-04 | 8-K | 8-K items 1.01,2.01,9.01 | 2026-06-03 |
| 2026-05-07 | 10-Q | 10-Q | 2026-03-31 |
| 2026-05-07 | 8-K | 8-K items 2.02,7.01,9.01 | 2026-05-07 |
| 2026-04-29 | DEFA14A | DEFA14A | |
| 2026-04-29 | ARS | ARS | 2025-12-31 |
Forms on file (last 1,000): 4 160, 8-K 71, 3 32, 4/A 26, 10-Q 17, SC 13G/A 9, EFFECT 8, DEF 14A 7. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=TRLV (0.002 USD), /gw/filings/filings?ticker=TRLV&form=8-K, /gw/filings/facts?ticker=TRLV&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange